Alzheimer is a multitargeting brain-hitting disease. The need to prepare and screen new agents is endless. Novel thienopyridine-tacrine analogues 4a,b – 8a,b and 9 have been designed, synthesized and biologically screened against cholinesterase inhibition activity. Two compounds 7a and 7b were found active. Compound 7b exceeded tacrine as a cholinesterase inhibitor. The docking studies explained this activity as compound 7b exhibited similar binding affinity to the acetylcholinesterase enzyme as with tacrine in addition to an extra hydrogen bonding
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report